SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-211424
Filing Date
2020-08-06
Accepted
2020-08-06 09:00:26
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d68625ds3.htm S-3 383193
2 EX-1.2 d68625dex12.htm EX-1.2 193529
3 EX-4.2 d68625dex42.htm EX-4.2 34831
4 EX-4.3 d68625dex43.htm EX-4.3 249255
5 EX-5.1 d68625dex51.htm EX-5.1 33758
6 EX-23.1 d68625dex231.htm EX-23.1 1941
7 GRAPHIC g68625g0804123731471.jpg GRAPHIC 53910
8 GRAPHIC g68625g0804123731658.jpg GRAPHIC 5989
9 GRAPHIC g68625g0804131910189.jpg GRAPHIC 43268
10 GRAPHIC g68625img_32.jpg GRAPHIC 6847
  Complete submission text file 0001193125-20-211424.txt   1042128
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-241443 | Film No.: 201080134
SIC: 2834 Pharmaceutical Preparations